As of 2025-12-29, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.42 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -102.2%.
The range of the Relative Valuation is (0.02) - (0.06) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | -0.8x - 0.2x | 0.1x |
| Fair Price | (0.02) - (0.06) | (0.03) |
| Upside | -101.8% - -104.4% | -102.2% |
| Date | P/E |